STOCK TITAN

HARMONY BIOSCIENCES TO PARTICIPATE IN 21st ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Harmony Biosciences Holdings, based in Plymouth Meeting, PA, will present a company update at the 21st Annual Needham Virtual Healthcare Conference on April 11, 2022. CEO John C. Jacobs will lead a fireside chat from 12:45 p.m. to 1:25 p.m. ET and participate in 1x1 meetings on the same day. Investors can access a webcast of the chat on Harmony's investor page. Harmony focuses on innovative therapies for rare neurological diseases, aiming to address unmet medical needs.

Positive
  • None.
Negative
  • None.

PLYMOUTH MEETING, Pa., April 4, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's President and CEO, John C. Jacobs, will present a company update and host investor meetings at the upcoming 21st Annual Needham Virtual Healthcare Conference.

  • 21st Annual Needham Virtual Healthcare Conference
    Fireside Chat: Monday, April 11; 12:45 p.m.-1:25 p.m. ET
    1x1 Meetings: Monday, April 11

A webcast of the fireside chat will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences
Harmony Biosciences is a commercial stage pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological disorders who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Patti Bank
ICR Westwicke
415-513-1284
ir@harmonybiosciences.com 

Harmony Biosciences Media Contact:
Nancy Leone
215-891-6046
nleone@harmonybiosciences.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-21st-annual-needham-virtual-healthcare-conference-301515924.html

SOURCE Harmony Biosciences

FAQ

When will Harmony Biosciences present at the Needham Virtual Healthcare Conference?

Harmony Biosciences will present on April 11, 2022.

Who is presenting for Harmony Biosciences at the conference?

CEO John C. Jacobs will present at the conference.

What time is Harmony Biosciences' fireside chat at the conference?

The fireside chat is scheduled for April 11, 2022, from 12:45 p.m. to 1:25 p.m. ET.

Where can I watch the Harmony Biosciences presentation?

The presentation can be viewed on Harmony's investor page.

What is Harmony Biosciences focused on?

Harmony Biosciences develops therapies for rare neurological diseases.

What is the ticker symbol for Harmony Biosciences?

The ticker symbol for Harmony Biosciences is HRMY.

Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

HRMY Rankings

HRMY Latest News

HRMY Stock Data

1.94B
38.55M
11.62%
93.1%
10.17%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PLYMOUTH MEETING